Lambert-Eaton Myasthenic syndrome in a child with an autoimmune phenotype
β Scribed by Hoffman, William H. ;Helman, Sandra W. ;Sekul, Elizabeth ;Carroll, James E. ;Vega, Roger A.
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 62 KB
- Volume
- 119A
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The high incidence of elevated immunoglobulin (Ig)G anti-GQ1b antibody in sera from patients with acute phase Miller-Fisher syndrome (MFS) was first reported by Chiba et al. 1 and later confirmed by two other groups. 3,4 Chiba et al. 2 pointed out that anti-GQ1b IgG antibody is associated specifical
Lambert-Eaton myasthenic syndrome (LEMS) is a neurological disorder characterized by reduced presynaptic release of acetylcholine.' Antibodies measured with o-conotoxin GVIA (GVIA), a long-lasting N-type calcium channel blocker, have been detected in 44-90% of patients with LEMS and in 10-42% of pat